Funeral planned for Clearfield County teen who died in house fire – Connect FM | Local News Radio connectradio.fm - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from connectradio.fm Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Greystar Real Estate Partners, LLC ("Greystar"), a global leader in the investment, development, and management of real estate, including.
Overwatch 2 will get its first public tests this week, followed by a closed beta next month.In a new dev update, game director Aaron Keeler said that while Blizzard was confident in its work so far, it wanted to ensure it got the game into players' hands as quickly as possible. Thanking fans for their ongoing support and apologizing for the team's lack of communication, Keller also said that Blizzard was "committed to more updates on all things Overwatch 2."
by Tracey Peake April 14, 2021 .
RALEIGH – Bacteria – such as E. coli – harness biosynthesis to create molecules that are difficult to make artificially.
“We already use bacteria to make a number of drugs for us,” says Edward Kalkreuter, former graduate student at NC State and lead author of a paper describing the research. “But we also want to make alterations to these compounds; for example, there’s a lot of drug resistance to erythromycin. Being able to make molecules with similar activity but improved efficacy against resistance is the general goal.”
Picture an automobile assembly line: each stop along the line features a robot that chooses a particular piece of the car and adds it to the whole. Now substitute erythromycin for the car, and an acyltransferase (AT) – an enzyme – as the robot at the stations along the assembly line. Each AT “robot” will select a chemical block, or extender unit, to add to the molecule. At each station the AT robot has
Date Time
Researchers Streamline Molecular Assembly Line to Design, Test Drug Compounds
Researchers from North Carolina State University have found a way to fine-tune the molecular assembly line that creates antibiotics via engineered biosynthesis. The work could allow scientists to improve existing antibiotics as well as design new drug candidates quickly and efficiently.
Bacteria – such as E. coli – harness biosynthesis to create molecules that are difficult to make artificially.
“We already use bacteria to make a number of drugs for us,” says Edward Kalkreuter, former graduate student at NC State and lead author of a paper describing the research. “But we also want to make alterations to these compounds; for example, there’s a lot of drug resistance to erythromycin. Being able to make molecules with similar activity but improved efficacy against resistance is the general goal.”